{"entity":{"type":"insider","cik":"0001398278","url":"/insider/0001398278","json_url":"/insider/0001398278.json","name":"Kelly Leanne M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":1,"first":"2021-06-04","last":"2021-06-04","span_basis":"filed_date"},"name_variants":[{"name":"Kelly Leanne M.","source":"filing","n_filings":1,"first_seen":"2021-06-04","last_seen":"2021-06-04"}],"transactions":[{"id":4312118,"accession":"0001104659-21-076998","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-076998","line_url":"/filing/0001104659-21-076998#line-3","is_derivative":false,"issuer_cik":"0001398278","issuer_name":"Vallon Pharmaceuticals, Inc.","issuer_ticker":"VLON","issuer_name_source":null,"issuer_url":"/issuer/0001398278","owner_cik":"0001398278","owner_name":"Kelly Leanne M.","owner_display_name":"Kelly Leanne M.","owner_url":"/insider/0001398278","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1508.0,"shares_display":"1,508","price_per_share":4.08,"price_display":"4.08","price_state":"stated","total_value":6152.64,"total_display":"6,152.64","total_whole":"6,153","shares_owned_after":6250.0,"shares_owned_after_display":"6,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-04","scope":"insider"},{"id":4312112,"accession":"0001104659-21-076998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-076998","line_url":"/filing/0001104659-21-076998#line-2","is_derivative":false,"issuer_cik":"0001398278","issuer_name":"Vallon Pharmaceuticals, Inc.","issuer_ticker":"VLON","issuer_name_source":null,"issuer_url":"/issuer/0001398278","owner_cik":"0001398278","owner_name":"Kelly Leanne M.","owner_display_name":"Kelly Leanne M.","owner_url":"/insider/0001398278","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1085.0,"shares_display":"1,085","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":4394.25,"total_display":"4,394.25","total_whole":"4,394","shares_owned_after":4742.0,"shares_owned_after_display":"4,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-04","scope":"insider"},{"id":4312108,"accession":"0001104659-21-076998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-076998","line_url":"/filing/0001104659-21-076998#line-1","is_derivative":false,"issuer_cik":"0001398278","issuer_name":"Vallon Pharmaceuticals, Inc.","issuer_ticker":"VLON","issuer_name_source":null,"issuer_url":"/issuer/0001398278","owner_cik":"0001398278","owner_name":"Kelly Leanne M.","owner_display_name":"Kelly Leanne M.","owner_url":"/insider/0001398278","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3657.0,"shares_display":"3,657","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":14628.0,"total_display":"14,628.00","total_whole":"14,628","shares_owned_after":3657.0,"shares_owned_after_display":"3,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001824293","name":"Vallon Pharmaceuticals, Inc.","url":"/issuer/0001824293","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2021-06-04","last_seen":"2021-06-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001398278","retrieved_at":"2026-08-23T06:09:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}